A case report of hypocomplementemic urticarial vasculitis presenting with membranoproliferative glomerulonephritis

BMC Nephrol. 2020 Aug 18;21(1):351. doi: 10.1186/s12882-020-02001-6.

Abstract

Background: Hypocomplementemic urticarial vasculitis syndrome is an infrequent condition characterized by ocular, renal, gastrointestinal and pulmonary involvement with low serum complement levels and autoantibodies. Renal manifestations vary from microscopic hematuria to nephrotic syndrome and acute kidney injury. Accordingly differing histologic patterns have been reported.

Case presentation: We present the case of a 65 years old woman with a history of chronic uveitis who presented with arthralgias, urticarial rush, nephrotic syndrome, glomerular hematuria and low serum complement. Kidney biopsy revealed an immune-complex membranoproliferative glomerulonephritis. The patient received induction therapy with steroids, cyclophosphamide and hydroxychloroquine followed by rapid clinical improvement and remission of proteinuria. Maintenance treatment consisted of rituximab pulses.

Conclusions: The majority of hypocomplementemic urticarial vasculitis syndrome cases is idiopathic, although an association to drugs, infections or other autoimmune disorders has been recorded. Given the rarity and heterogeneity of the disease, no standard treatment is established.

Keywords: Case report; Complement; Hypocomplementemic urticarial vasculitis syndrome; Renal disease; Vasculitis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antirheumatic Agents / therapeutic use
  • Arthritis / complications
  • Chronic Urticaria / complications*
  • Chronic Urticaria / drug therapy
  • Chronic Urticaria / metabolism
  • Complement System Proteins / metabolism*
  • Cyclophosphamide / therapeutic use
  • Female
  • Glomerulonephritis, Membranoproliferative / complications*
  • Glomerulonephritis, Membranoproliferative / drug therapy
  • Glomerulonephritis, Membranoproliferative / metabolism
  • Glomerulonephritis, Membranoproliferative / pathology
  • Glucocorticoids / therapeutic use
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Nephrotic Syndrome / complications*
  • Nephrotic Syndrome / drug therapy
  • Nephrotic Syndrome / metabolism
  • Nephrotic Syndrome / pathology
  • Proteinuria / metabolism
  • Rituximab / therapeutic use
  • Uveitis / complications*
  • Uveitis / drug therapy
  • Uveitis / metabolism
  • Vasculitis / complications*
  • Vasculitis / drug therapy
  • Vasculitis / metabolism

Substances

  • Antirheumatic Agents
  • Glucocorticoids
  • Rituximab
  • Hydroxychloroquine
  • Cyclophosphamide
  • Complement System Proteins